RecruitingACTRN12612001011875

Ten Year Survivorship and Clinical Outcome of the Genesis II Prosthesis for Total Knee Replacement


Sponsor

Associate Professor Leo Pinczewski

Enrollment

340 participants

Start Date

Jan 1, 2012

Study Type

Observational

Conditions

Summary

This study examines survivorship and the clinical outcome in a series of 340 consecutive patients 10 years after TKR with the Genesis II prosthesis. All arthroplasties were performed by a single surgeon over a 3 year period.


Eligibility

Sex: Both males and females

Plain Language Summary

Simplified for easier understanding

This study is following up on 340 patients who had a total knee replacement (TKR) using the Genesis II prosthesis to see how well their artificial knee has held up over 10 years. Researchers want to know how many knees are still working well, what the pain and function levels are, and what complications have occurred over the long term. This kind of long-term data helps orthopaedic surgeons make better decisions for future patients. You may be eligible if: - You previously had a primary total knee replacement using the Genesis II prosthesis - Your surgery was performed by the specific surgeon involved in this study - You do not have rheumatoid arthritis - Before your surgery, your knee had a fixed flexion deformity of less than 15 degrees - You are willing to participate in a research program You may NOT be eligible if: - You are seeking legal compensation for your knee condition Talk to your doctor about whether this trial might be right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Clinical and Radiological outcome of Total Knee Replacement over 10 years

Clinical and Radiological outcome of Total Knee Replacement over 10 years


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612001011875